Janux Therapeutics (JANX) IPO Doubles on Open

June 11, 2021 10:57 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's IPO for Janux Therapeutics (NASDAQ: JANX) opened for trading at $34 after pricing 11,400,000 shares of its common stock at $17.

BofA Securities, Cowen and Evercore ISI are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.

Janux Therapeutics is a biopharmaceutical company developing novel T cell engager immunotherapies.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot IPOs, IPOs, Momentum Movers, Trader Talk

Related Entities

Cowen & Co, IPO, H.C. Wainwright